Axa’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,500
Closed -$1.14M 1181
2022
Q4
$1.14M Sell
23,500
-400
-2% -$25.1K ﹤0.01% 862
2022
Q3
$1.69M Buy
23,900
+12,100
+103% +$1.04M 0.01% 785
2022
Q2
$837K Sell
11,800
-3,400
-22% -$219K ﹤0.01% 902
2022
Q1
$1.21M Sell
15,200
-49,200
-76% -$3.66M ﹤0.01% 922
2021
Q4
$5.88M Sell
64,400
-22,500
-26% -$2.41M 0.02% 621
2021
Q3
$11.2M Buy
86,900
+34,700
+66% +$4.86M 0.03% 466
2021
Q2
$7.96M Buy
+52,200
New +$6.88M 0.02% 579
2019
Q3
Sell
-11,213
Closed -$329K 1351
2019
Q2
$329K Sell
11,213
-29,587
-73% -$854K ﹤0.01% 1149
2019
Q1
$1.4M Sell
40,800
-44,600
-52% -$1.58M 0.01% 915
2018
Q4
$2.73M Buy
85,400
+54,000
+172% +$2.1M 0.01% 760
2018
Q3
$1.51M Buy
31,400
+16,222
+107% +$664K 0.01% 942
2018
Q2
$471K Buy
+15,178
New +$355K ﹤0.01% 1146

Other funds holding STAA

Axa's STAA Position: Q1 2023 in Review

Axa sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 23,500 shares — an estimated $1.14M sold.

Axa first reported a position in STAA in Q2 2018 and held it in 12 quarters. The position peaked at $11.2M in Q3 2021. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.

  • Axa reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
  • Axa sold 23,500 STAAR Surgical shares in Q1 2023, an estimated $1.14M.
  • Axa first reported a position in STAAR Surgical in Q2 2018 and held it in 12 quarters.
  • Axa's STAAR Surgical position peaked at $11.2M in Q3 2021.
  • 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.

Based on Axa's 13F filing for Q1 2023, filed 15 May 2023.